Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells

World Journal of Gastroenterology

Volumn 7, Issue 5, 2001, Pages 690-694

  Zhang, J ^a   Zhang, J K ^a   Zhuo, S H ^a   Chen, H B ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; METRIZAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL CULTURE; CELL FUSION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DENSITY GRADIENT CENTRIFUGATION; DRUG EFFECT; DRUG SYNTHESIS; GROWTH CURVE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MORPHOLOGY; MOUSE; NONHUMAN; SPLEEN;

EID: 0034782337     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i5.690     Document Type: Article

References (50)

1. Reciprocal control of T helper cell land dendritic cell differentiation
2. Myeloid dendritic cells
3. T cells and dendritic cells get intimate
4. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
5. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
6. Migration of human dendritic cells after injection in patients with metastatic malignancies
7. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells
8. Immunotherapy of cancer with dendritic cell based vaccines
9. Effect of dendritic cells on LPAK cells induced at different times in killing hepatoma cells
10. Promoting effects of dendritic cells on LPAK cells killing human hepatoma cells
11. Effects of cytokines on dendritic cells against human hepatoma cell line
12. Induction of primary human antigen specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides
13. Dendritic cells and the control of immunity
14. Dendritic cells
15. Relationship between infiltration of dendritic cells, pericancerous lymphocytic reaction and prognosis in colorectal carcinomas
16. Expression of B7 costimulation molecules by colorectal cancer cells reduces tumorigenicity and induces anti-tumor immunity
17. Retrovirally transduced bone marrow-derived dendritic cells require CD4 + T cell help to elicit protective and therapeutic antitumor immunity
18. Type I IFNs enhance the terminal differentiation of dendritic cells
19. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
20. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
21. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures
22. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma
23. Dendritic cells and the control of immunity
24. In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction
25. Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines
26. Construction and expression of mouse/humanized scFv and their fusion to humanized mutant TNFα against hepatocellular carcinoma
27. Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis highly restricted distribution of CD83 positive activated dendritic cells
28. Effect of lipid on proliferation and activation of rat hepatic stellate cells (I)
29. Dendritic cells in vitro induce efficient and special anti-tumor immune response
30. Immune response induced by dendritic cells induce apoptosis and inhibits proliferation of tumor cells
31. Study of the phenotype of PBLs activated by CD28/ CD80 and CD2/ CD58 and acting with hepatoma cells and the restricted usage of TCR Vβ gene subfamily
32. CD54, CD80, CD86 and HLA-ABC expressions in liver cirrhosis and hepatocarcinoma
33. Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells
34. Immortalized cell lines derived from mice lacking both type I and type II IFN receptors unify some functions of immature and mature dendritic cells
35. Unique features of dendritic cells in IFN-gamma transgenic mice: Relevance to cancer development and therapeutic implications
36. Increased nitric oxide (NO) production by antigen presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC)
37. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus infected individuals
38. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
39. Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells
40. Rapid generation of broad T cell immunity in humans after a single injection of mature dendritic cells
41. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
42. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
43. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines
44. Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity
45. d mice
46. Progvesses in surgical treatment of primary hepatocellular carcinoma
47. Effect of embryo hepatic extracts on proliferation and differentiation of hepatoma BEL-7402 cells
48. Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier
49. Dendritic cells in vitro induce efficient and special anti-tumor immune response
50. Rapid generation of broad T cell immunity in humans after a single injection of mature dendritic cells